<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-01745R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0001395</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Public Health and Epidemiology</subject><subject>Genetics and Genomics/Genetics of Disease</subject><subject>Genetics and Genomics/Genetics of the Immune System</subject><subject>Cardiovascular Disorders/Cardiovascular Diseases in Women</subject><subject>Cardiovascular Disorders/Coronary Artery Disease</subject></subj-group></article-categories><title-group><article-title>C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies</article-title><alt-title alt-title-type="running-head">CRP SNPs and CHD</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pai</surname><given-names>Jennifer K.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mukamal</surname><given-names>Kenneth J.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rexrode</surname><given-names>Kathryn M.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rimm</surname><given-names>Eric B.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Kronenberg</surname><given-names>Florian</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Innsbruck Medical University, Austria</aff><author-notes><corresp id="cor1">&#x0002a; To whom correspondence should be addressed. E-mail: <email>jpai@hsph.harvard.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: JP KM KR ER. Analyzed the data: JP KM ER. Wrote the paper: JP. Other: Provided statistical support and manuscript editing: KM KR. Provided data collection: KR ER. Provided funding: ER. Provided manuscript writing: ER.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>2</day><month>1</month><year>2008</year></pub-date><volume>3</volume><issue>1</issue><elocation-id>e1395</elocation-id><history><date date-type="received"><day>12</day><month>7</month><year>2007</year></date><date date-type="accepted"><day>6</day><month>12</month><year>2007</year></date></history><copyright-statement>Pai et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><sec><title>Background</title><p>C-reactive protein (CRP), an acute phase reactant and marker of inflammation, has been shown to predict risk of incident cardiovascular events. However, few studies have comprehensively examined six common single-nucleotide polymorphisms (SNPs) in the CRP gene, haplotypes, and plasma CRP levels with risk of coronary heart disease (CHD).</p></sec><sec><title>Methods and Findings</title><p>We conducted parallel nested case-control studies within two ongoing, prospective cohort studies of U.S. women (Nurses' Health Study) and men (Health Professionals Follow-up Study). Blood samples were available in a subset of 32,826 women and 18,225 men for biomarker and DNA analyses. During 8 and 6 years of follow-up, 249 women and 266 men developed incident nonfatal myocardial infarction or fatal CHD, and controls (498 women, 531 men) were matched 2:1 on age, smoking, and date of blood draw from participants free of cardiovascular disease at the time the case was diagnosed. Among both women and men, minor alleles were significantly associated with higher CRP levels for SNPs 1919A&#x0003e;T and 4741G&#x0003e;C, but associated with lower CRP levels for SNPs 2667G&#x0003e;C and 3872C&#x0003e;T. SNP 2667G&#x0003e;C was individually associated with increased risk of CHD in both women &#x0005b;OR 1.57 (95&#x00025; CI 1.01&#x02013;2.44); p&#x0200a;&#x0003d;&#x0200a;0.047&#x0005d; and men &#x0005b;1.93 (95&#x00025; CI 1.30&#x02013;2.88); p&#x0200a;&#x0003d;&#x0200a;0.001&#x0005d;. Two of the five common haplotypes were associated with lower CRP levels, and Haplotype 4 which included minor alleles for 2667 and 3872 was associated with significantly lower CRP levels and an elevated risk of CHD. The remaining SNPs or haplotypes were not associated with CHD in both populations.</p></sec><sec><title>Conclusions</title><p>Common variation in the CRP gene was significantly associated with plasma CRP levels; however, the association between common SNPs and CRP levels did not correspond to a predicted change in CHD risk. The underlying inflammatory processes which predict coronary events cannot be captured solely by variation in the CRP gene.</p></sec></abstract><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Inflammatory processes are involved in the initiation and progression of atherosclerotic lesions, as well as in the development of atheroma complications,<xref ref-type="bibr" rid="pone.0001395-Libby1">&#x0005b;1&#x0005d;</xref> and markers of inflammation may reflect subclinical vascular inflammation and be useful diagnostic tools.<xref ref-type="bibr" rid="pone.0001395-Szalai1">&#x0005b;2&#x0005d;</xref> C-reactive protein (CRP), an acute phase reactant, is a marker of inflammation, and has been shown to independently predict risk of future cardiovascular events among initially healthy men and women.<xref ref-type="bibr" rid="pone.0001395-Ridker1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001395-Danesh1">&#x0005b;6&#x0005d;</xref> However, since CRP levels can be influenced by age, smoking, body mass index, and other clinical or environmental risk factors,<xref ref-type="bibr" rid="pone.0001395-Ledue1">&#x0005b;7&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001395-Kathiresan1">&#x0005b;9&#x0005d;</xref> it remains to be determined whether CRP acts causally in atherogenesis, in addition to serving as a reliable marker of future events.<xref ref-type="bibr" rid="pone.0001395-deMaat1">&#x0005b;10&#x0005d;</xref></p><p>Recent family studies suggest heritability estimates of CRP ranging from 27&#x02013;40&#x00025;,<xref ref-type="bibr" rid="pone.0001395-Pankow1">&#x0005b;11&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Dupuis1">&#x0005b;12&#x0005d;</xref> and it is hypothesized that genetic variation in the CRP gene may influence plasma CRP levels and subsequent risk of CHD. Several studies have reported individual single nucleotide polymorphisms (SNPs) to be associated with CRP levels,<xref ref-type="bibr" rid="pone.0001395-Brull1">&#x0005b;13&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001395-Crawford1">&#x0005b;21&#x0005d;</xref> and of these, Zee et al.,<xref ref-type="bibr" rid="pone.0001395-Zee1">&#x0005b;15&#x0005d;</xref> which included SNP 2667G&#x0003e;C, Casas et al.,<xref ref-type="bibr" rid="pone.0001395-Casas1">&#x0005b;19&#x0005d;</xref> which included SNP 3014G&#x0003e;A, also examined associations with cardiovascular events. Both studies reported no association with the individual SNPs and risk of cardiovascular disease.</p><p>To date, few studies of both men and women have simultaneously examined common genetic variation in the CRP gene, haplotypes, plasma CRP levels, and risk of incident cardiovascular events. In the Rotterdam Study, the common haplotypes associated with higher CRP levels were not associated with risk of coronary heart disease.<xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref> Similarly, among men in the Physicians' Health Study, none of the common SNPs associated with higher CRP levels were associated with an increased risk of atherothrombotic events, whereas one SNP not associated with CRP was associated with a decreased risk of myocardial infarction.<xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref> Alternatively, in the Cardiovascular Health Study among elderly adults, haplotypes were significantly associated with CRP levels, and stroke and cardiovascular mortality, but not associated with myocardial infarction.<xref ref-type="bibr" rid="pone.0001395-Lange1">&#x0005b;24&#x0005d;</xref> Because these studies included some, but not all of the same SNPs, estimated haplotypes are not directly comparable, and thus, summary conclusions cannot be made. Utilizing the existing sequencing data and available haplotype-tagging SNPs, we set out to comprehensively examine common variation in the CRP gene with plasma CRP levels and risk of incident coronary heart disease among two independent populations of middle-aged men and women.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Study Population</title><p>The Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS) are prospective cohort investigations among 121,700 female U.S. registered nurses aged 30&#x02013;55 years at baseline in 1976 (NHS) and 51,529 U.S. male health professionals, aged 40&#x02013;75 years at baseline in 1986 (HPFS). Information about health and disease is assessed biennially and information about diet every four years by self-administered questionnaires.<xref ref-type="bibr" rid="pone.0001395-Colditz1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Rimm1">&#x0005b;26&#x0005d;</xref> Between 1989 and 1990, a blood sample was requested from all participants of the NHS, and returned from 32,826 women. Similarly, between 1993 and 1995, a blood sample was returned from 18,225 men in the HPFS. Participants who provided blood samples were similar in terms of cardiovascular risk factors to those who did not, albeit somewhat younger. In the NHS, among women without cardiovascular disease or cancer prior to blood draw, we identified 249 women with incident nonfatal myocardial infarction (MI) or fatal coronary heart disease (CHD) over 8 years of follow-up. In the HPFS, we similarly identified 266 men with incident nonfatal MI or fatal CHD over 6 years of follow-up. Using risk-set sampling which selects controls from the base population that gave rise to the cases,<xref ref-type="bibr" rid="pone.0001395-Prentice1">&#x0005b;27&#x0005d;</xref> controls were randomly selected 2:1 matched on age, smoking, date of blood draw, and fasting status (women only) from participants free of cardiovascular disease at the time the case was diagnosed.</p><p>The study protocol was approved by the Institutional Review Board of the Brigham and Women's Hospital and the Harvard School of Public Health Human Subjects Committee Review Board.</p></sec><sec id="s2b"><title>Assessment of coronary heart disease</title><p>Myocardial infarction was confirmed by study physicians blinded to participant's exposure status if it met the World Health Organization's criteria (symptoms plus either diagnostic electrocardiographic changes or elevated levels of cardiac enzymes).<xref ref-type="bibr" rid="pone.0001395-Rose1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Luepker1">&#x0005b;29&#x0005d;</xref> Deaths were identified from state vital records and the National Death Index or reported by the participant's next of kin or the postal system. Fatal coronary heart disease was confirmed by hospital records or on autopsy, or if coronary heart disease was listed as the cause of death on the death certificate, if it was the underlying and most plausible cause, and if evidence of previous coronary heart disease was available. Among women, 80.3&#x00025; of the cases were nonfatal MI, and 19.7&#x00025; were fatal CHD. Among men, 73.7&#x00025; of the cases were nonfatal MI, and 26.3&#x00025; were fatal CHD.</p></sec><sec id="s2c"><title>Measurement of biochemical variables</title><p>Blood samples were collected in sodium heparin tubes for women and liquid EDTA for men, placed on ice packs, stored in Styrofoam containers, returned to our laboratory via overnight courier, and centrifuged and aliquoted for storage in liquid nitrogen freezers (&#x02212;130&#x000b0;C or colder). Inflammatory marker levels were largely unaffected by transport conditions and reproducible within persons over time.<xref ref-type="bibr" rid="pone.0001395-Pai2">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Pischon1">&#x0005b;31&#x0005d;</xref></p><p>Plasma biomarkers were measured for nonfatal MI and fatal CHD cases and their controls. C-reactive protein concentrations were determined using an immunoturbidimetric high sensitivity assay using reagents and calibrators from Denka Seiken (Niigata, Japan) with assay day-to-day variability between 1 and 2&#x00025;. This assay has a sensitivity of 0.1 mg/L, and the day-to-day variability of the assay at concentrations of 0.91, 3.07, and 13.38 mg/L were 2.8, 1.6, and 1.1&#x00025;, respectively. The intra-assay coefficients of variation were &#x0003c;10&#x00025; for both HPFS and NHS. Total, HDL, and directly assessed LDL cholesterol, and triglycerides were measured using standard methods with reagents from Roche Diagnostics (Indianapolis, IN) and Genzyme (Cambridge, MA). Study samples were sent to the laboratory for analysis in randomly ordered batches, and the laboratory was blinded to case-control status.</p></sec><sec id="s2d"><title>SNP selection and genotyping</title><p>To comprehensively assess the genetic variation in the CRP gene, we utilized a multi-stage approach. (1.) First, Carlson et al.<xref ref-type="bibr" rid="pone.0001395-Carlson1">&#x0005b;32&#x0005d;</xref> had resequenced the CRP gene in 23 unrelated European-descent individuals (EA) in the Utah/Centre d'Etude du Polymorphisme Humain (CEPH) panel (Coriell Institute for Medical Research, Camden, NJ), and using linkage disequilibrium had selected tagSNPs that summarized the common variation in the CRP gene. The five tagSNPs polymorphic in EAs, included a triallelic 1440C&#x0003e;T&#x0003e;A (rs3091244) and a commonly studied rare 2667G&#x0003e;C. (2.) Additionally, we conducted a comprehensive search of SNPs available in dbSNP (as of August 2005) which were polymorphic in Caucasians and had a minor allele frequency &#x0003e;1&#x00025;, and resulted in two additional SNPs with low minor allele frequency (MAF) &#x0005b;4362G&#x0003e;C and 5606G&#x0003e;T&#x0005d;. (3.) Finally, the International HapMap Project<xref ref-type="bibr" rid="pone.0001395-The1">&#x0005b;33&#x0005d;</xref> showed that two tagSNPs &#x0005b;1919A&#x0003e;T and 3872C&#x0003e;T&#x0005d; were sufficient to assess the variation in the gene, and these two were already included in the selected SNPs. The triallelic SNP could not be genotyped using Taqman; however, previous LD analyses<xref ref-type="bibr" rid="pone.0001395-Kathiresan1">&#x0005b;9&#x0005d;</xref> showed that SNPs 3872C&#x0003e;T and 5237A&#x0003e;G together serve as a proxy so these two SNPs were used instead.</p><p>DNA was extracted from the buffy coat fraction of centrifuged blood using the QIAmp Blood Kit (Qiagen, Chatsworth, CA). The primary genotyping technique was Taqman SNP allelic discrimination by means of an ABI 7900HT (Applied Biosystems, Foster City, CA) and the primers and probes used were designed by Applied Biosystems: 1919A&#x0003e;T (rs1417938), 2667G&#x0003e;C (rs1800947), 3014G&#x0003e;A (rs1130864), 3872C&#x0003e;T (rs1205), 4362A&#x0003e;T (rs3093080), 4741G&#x0003e;C (rs3093068), 5237A&#x0003e;G (rs2808630), and 5606G&#x0003e;T (rs3093071). Replicate quality control samples were included and genotyped with 100&#x00025; concordance. Cases were not perfectly matched to controls because a few subjects could not be genotyped with this platform, but genotype call rates did not differ between cases and controls. We initially genotyped the NHS, and then conducted a replication study in the HPFS. Among NHS, the minor allele frequencies for 4362A&#x0003e;T (0.6&#x00025; cases, 1.1&#x00025; controls) and 5606G&#x0003e;T (1&#x00025; cases, 0.5&#x00025; controls) were very low; thus, we did not further genotype them in the HPFS. The remaining 6 SNPs were selected for final analyses.</p></sec><sec id="s2e"><title>Statistical analyses</title><p>All analyses were conducted separately for men and women. For baseline characteristics, we used ANOVA methods to compare least square means adjusted for matching factors, and the Chi-square and/or Fisher's Exact tests to compare proportions between cases and controls, between genotype and allele frequencies, and to assess Hardy-Weinberg equilibrium. The primary genetic model was additive (genotype as a continuous variable). Conditional and unconditional logistic regression adjusting for matching factors and multivariate covariates were used to estimate the relative risk (RR) and results were similar. With risk-set sampling, the odds ratio derived from the logistic regression directly estimates the hazard ratio, and thus, the relative risk.<xref ref-type="bibr" rid="pone.0001395-Prentice1">&#x0005b;27&#x0005d;</xref> In our multivariable model we further adjusted for alcohol intake (nondrinker, 0.1 to 4.9 g/d, 5.0 to 14.9 g/d, 15.0 to 29.9 g/d, &#x02265;30.0 g/d), body mass index (&#x0003c;25, 25 to 29.9, &#x02265;30 kg/m<sup>2</sup>), physical activity (quintiles), nonsteroidal anti-inflammatory drug (NSAID) use (yes/no), parental history of CHD before the age of 60 (yes/no), history of diabetes (yes/no) and hypertension (yes/no) at baseline, total:HDL-cholesterol ratio (quintiles), and hormone therapy among women (never, past, current). Baseline was defined as the year of blood draw. Lewontin's D prime (D') and the correlation coefficient (r<sup>2</sup>) were calculated as two measures of linkage disequilibrium (LD) between CRP polymorphisms among control participants. CRP levels were not normally distributed and were log-transformed for analyses. Multivariable linear regression analyses were conducted to model the association between CRP SNPs and CRP levels among control participants.</p><p>Using an expectation-maximization algorithm in SAS Genetics, we estimated frequencies for the five most common (&#x0003e;5&#x00025; frequency) haplotypes in each population and imputed subject-specific expected haplotypes.<xref ref-type="bibr" rid="pone.0001395-Zaykin1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Kraft1">&#x0005b;35&#x0005d;</xref> Haplotype-specific odds ratios based on the additive model were calculated using unconditional logistic regression adjusting for matching factors with the most frequent haplotype set as the reference. The likelihood ratio test was used to calculate the global p-value comparing the model with haplotypes to the model without haplotypes. We present otherwise uncorrected p-values, and emphasize the 95&#x00025; confidence intervals around risk estimates from two independent populations.</p><p>All p-values presented are two-tailed and p-values below 0.05 were considered statistically significant. All analyses were performed using SAS version 9 (SAS Institute, Cary, NC).</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Baseline characteristics</title><p>Cardiovascular risk factors were higher or more frequent among the cases compared to the controls in both men and women (<xref ref-type="table" rid="pone-0001395-t001"><bold>Table 1</bold></xref>), and for most of the CRP genotype frequencies, there were no statistical differences by case and control status (<xref ref-type="table" rid="pone-0001395-t002"><bold>Table 2</bold></xref>). The 2667C allele was significantly more frequent among cases than controls in women (p&#x0200a;&#x0003d;&#x0200a;0.05) and men (0.006), and the 5237G allele was more frequent among cases then controls in women only (p&#x0200a;&#x0003d;&#x0200a;0.004). The observed allele frequencies for all SNPs, except for 5237A&#x0003e;G among women (p&#x0200a;&#x0003d;&#x0200a;0.03) and 4741G&#x0003e;C among men (p&#x0200a;&#x0003d;&#x0200a;0.001), were within Hardy-Weinberg equilibrium among the controls. The pairwise LD measures and correlation coefficients between CRP polymorphisms were analyzed among the control women and men (<xref ref-type="table" rid="pone-0001395-t003"><bold>Table 3</bold></xref>). The minor alleles for 1919A&#x0003e;T and 3014G&#x0003e;A were in high pairwise LD (r<sup>2</sup>&#x0003e;0.95), whereas 2667G&#x0003e;C, 3872C&#x0003e;T, 4741G&#x0003e;C, and 5237A&#x0003e;G were not in high LD (r<sup>2</sup>&#x0003c;0.30).</p><table-wrap id="pone-0001395-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001395.t001</object-id><label>Table 1</label><caption><title>Baseline characteristics of participants with incident CHD (cases) and matched<xref ref-type="table-fn" rid="nt101">&#x0002a;</xref> controls among women (Nurses' Health Study) and men (Health Professionals Follow-up Study)<xref ref-type="table-fn" rid="nt102">&#x02020;</xref></title></caption><graphic id="pone-0001395-t001-1" xlink:href="pone.0001395.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001395-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Women</td><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Men</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Characteristics</td><td align="left" rowspan="1" colspan="1">Cases</td><td align="left" rowspan="1" colspan="1">Controls</td><td align="left" rowspan="1" colspan="1">P<xref ref-type="table-fn" rid="nt103">&#x02021;</xref></td><td align="left" rowspan="1" colspan="1">Cases</td><td align="left" rowspan="1" colspan="1">Controls</td><td align="left" rowspan="1" colspan="1">P<xref ref-type="table-fn" rid="nt103">&#x02021;</xref></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">249</td><td align="left" rowspan="1" colspan="1">498</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">266</td><td align="left" rowspan="1" colspan="1">531</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">60.3 &#x000b1; 0.09</td><td align="left" rowspan="1" colspan="1">60.3 &#x000b1; 0.06</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">65.2 &#x000b1; 0.13</td><td align="left" rowspan="1" colspan="1">65.1 &#x000b1; 0.09</td><td align="left" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" rowspan="1" colspan="1">Current Smokers (&#x00025;)</td><td align="left" rowspan="1" colspan="1">32.1</td><td align="left" rowspan="1" colspan="1">31.9</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">12.7</td><td align="left" rowspan="1" colspan="1">12.7</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Caucasian<xref ref-type="table-fn" rid="nt104">&#x000a7;</xref> (&#x00025;)</td><td align="left" rowspan="1" colspan="1">96.1</td><td align="left" rowspan="1" colspan="1">96.5</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">98.1</td><td align="left" rowspan="1" colspan="1">98.4</td><td align="left" rowspan="1" colspan="1">&#x0003e;0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">Postmenopausal (&#x00025;)</td><td align="left" rowspan="1" colspan="1">90.3</td><td align="left" rowspan="1" colspan="1">87.8</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">26.9 &#x000b1; 0.31</td><td align="left" rowspan="1" colspan="1">25.4 &#x000b1; 0.22</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1">26.2 &#x000b1; 0.21</td><td align="left" rowspan="1" colspan="1">25.7 &#x000b1; 0.15</td><td align="left" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">History of hypertension (&#x00025;)</td><td align="left" rowspan="1" colspan="1">57.4</td><td align="left" rowspan="1" colspan="1">29.3</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1">42.1</td><td align="left" rowspan="1" colspan="1">30.9</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">History of diabetes (&#x00025;)</td><td align="left" rowspan="1" colspan="1">19.7</td><td align="left" rowspan="1" colspan="1">6.6</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1">9.4</td><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">Parental history of CHD before age 60 (&#x00025;)</td><td align="left" rowspan="1" colspan="1">27.7</td><td align="left" rowspan="1" colspan="1">12.3</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1">15.0</td><td align="left" rowspan="1" colspan="1">10.9</td><td align="left" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" rowspan="1" colspan="1">Total:HDL-cholesterol ratio</td><td align="left" rowspan="1" colspan="1">4.88 &#x000b1; 0.09</td><td align="left" rowspan="1" colspan="1">4.05 &#x000b1; 0.06</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1">5.37 &#x000b1; 0.09</td><td align="left" rowspan="1" colspan="1">4.75 &#x000b1; 0.06</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">CRP (mg/L)</td><td align="left" rowspan="1" colspan="1">3.08 (2.67, 3.55)</td><td align="left" rowspan="1" colspan="1">2.16 (1.95, 2.39)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1">1.58 (1.38, 1.80)</td><td align="left" rowspan="1" colspan="1">1.17 (1.07, 1.29)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label>&#x0002a;</label><p>Matched on age, smoking status, date of blood drawing, and fasting status (women only)</p></fn><fn id="nt102"><label>&#x02020;</label><p>Values are least square mean &#x000b1; standard error for continuous variables and proportions for categorical variables, except for CRP, which is shown as log-transformed geometric mean and 95&#x00025; confidence interval</p></fn><fn id="nt103"><label>&#x02021;</label><p>P for difference between cases and controls by matching factor-adjusted t-Test for rows with means, and by Chi-Square Test for rows with proportions</p></fn><fn id="nt104"><label>&#x000a7;</label><p>Race unknown in 10 cases and 21 controls (HPFS); 18 cases and 16 controls (NHS)</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0001395-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001395.t002</object-id><label>Table 2</label><caption><title>Genotype frequency for CRP polymorphisms among cases and controls in Nurses' Health Study (Women) and Health Professionals Follow-up Study (Men)</title></caption><graphic id="pone-0001395-t002-2" xlink:href="pone.0001395.t002"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001395-t002-2"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Women</td><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Men</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cases</td><td align="left" rowspan="1" colspan="1">Controls</td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt105">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">Cases</td><td align="left" rowspan="1" colspan="1">Controls</td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt105">&#x0002a;</xref></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>1919A&#x0003e;T</bold></td><td align="left" rowspan="1" colspan="1">rs1417938</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">122 (51.7)</td><td align="left" rowspan="1" colspan="1">231 (49.6)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">122 (50.0)</td><td align="left" rowspan="1" colspan="1">234 (48.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AT</td><td align="left" rowspan="1" colspan="1">93 (39.4)</td><td align="left" rowspan="1" colspan="1">185 (39.7)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">98 (40.2)</td><td align="left" rowspan="1" colspan="1">201 (41.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">21 (8.9)</td><td align="left" rowspan="1" colspan="1">50 (10.7)</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">24 (9.8)</td><td align="left" rowspan="1" colspan="1">52 (10.7)</td><td align="left" rowspan="1" colspan="1">0.87</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">236</td><td align="left" rowspan="1" colspan="1">466</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">244</td><td align="left" rowspan="1" colspan="1">487</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>2667G&#x0003e;C</bold></td><td align="left" rowspan="1" colspan="1">rs1800947</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">205 (85.1)</td><td align="left" rowspan="1" colspan="1">433 (89.8)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">209 (81.0)</td><td align="left" rowspan="1" colspan="1">458 (89.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GC</td><td align="left" rowspan="1" colspan="1">35 (14.5)</td><td align="left" rowspan="1" colspan="1">49 (10.2)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">45 (17.4)</td><td align="left" rowspan="1" colspan="1">51 (9.9)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1">1 (0.41)</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1">4 (1.6)</td><td align="left" rowspan="1" colspan="1">4 (0.8)</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">241</td><td align="left" rowspan="1" colspan="1">482</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">258</td><td align="left" rowspan="1" colspan="1">513</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>3014G&#x0003e;A</bold></td><td align="left" rowspan="1" colspan="1">rs1130864</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">125 (52.7)</td><td align="left" rowspan="1" colspan="1">238 (51.0)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">126 (50.8)</td><td align="left" rowspan="1" colspan="1">235 (47.8)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GA</td><td align="left" rowspan="1" colspan="1">94 (39.7)</td><td align="left" rowspan="1" colspan="1">178 (38.1)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">98 (39.5)</td><td align="left" rowspan="1" colspan="1">205 (41.7)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">18 (7.6)</td><td align="left" rowspan="1" colspan="1">51 (10.9)</td><td align="left" rowspan="1" colspan="1">0.39</td><td align="left" rowspan="1" colspan="1">24 (9.7)</td><td align="left" rowspan="1" colspan="1">52 (10.6)</td><td align="left" rowspan="1" colspan="1">0.73</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">237</td><td align="left" rowspan="1" colspan="1">467</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">248</td><td align="left" rowspan="1" colspan="1">492</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>3872C&#x0003e;T</bold></td><td align="left" rowspan="1" colspan="1">rs1205</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1">107 (44.4)</td><td align="left" rowspan="1" colspan="1">210 (44.2)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">111 (43.7)</td><td align="left" rowspan="1" colspan="1">237 (46.7)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1">108 (44.8)</td><td align="left" rowspan="1" colspan="1">225 (47.4)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">113 (44.5)</td><td align="left" rowspan="1" colspan="1">222 (43.7)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TT</td><td align="left" rowspan="1" colspan="1">26 (10.8)</td><td align="left" rowspan="1" colspan="1">40 (8.4)</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">30 (11.8)</td><td align="left" rowspan="1" colspan="1">49 (9.6)</td><td align="left" rowspan="1" colspan="1">0.57</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">241</td><td align="left" rowspan="1" colspan="1">475</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">254</td><td align="left" rowspan="1" colspan="1">508</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>4741G&#x0003e;C</bold></td><td align="left" rowspan="1" colspan="1">rs3093068</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">206 (86.6)</td><td align="left" rowspan="1" colspan="1">419 (89.2)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">233 (90.0)</td><td align="left" rowspan="1" colspan="1">435 (86.5)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GC</td><td align="left" rowspan="1" colspan="1">32 (13.5)</td><td align="left" rowspan="1" colspan="1">48 (10.2)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">25 (9.6)</td><td align="left" rowspan="1" colspan="1">60 (11.9)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1">0 (0.0)</td><td align="left" rowspan="1" colspan="1">3 (0.64)</td><td align="left" rowspan="1" colspan="1">0.22</td><td align="left" rowspan="1" colspan="1">1 (0.4)</td><td align="left" rowspan="1" colspan="1">8 (1.6)</td><td align="left" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">238</td><td align="left" rowspan="1" colspan="1">470</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">259</td><td align="left" rowspan="1" colspan="1">503</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>5237A&#x0003e;G</bold></td><td align="left" rowspan="1" colspan="1">rs2808630</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">126 (52.3)</td><td align="left" rowspan="1" colspan="1">216 (45.4)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">124 (51.0)</td><td align="left" rowspan="1" colspan="1">256 (51.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">85 (35.3)</td><td align="left" rowspan="1" colspan="1">224 (47.1)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">96 (39.5)</td><td align="left" rowspan="1" colspan="1">204 (40.9)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">30 (12.5)</td><td align="left" rowspan="1" colspan="1">36 (7.6)</td><td align="left" rowspan="1" colspan="1">0.004</td><td align="left" rowspan="1" colspan="1">23 (9.5)</td><td align="left" rowspan="1" colspan="1">39 (7.8)</td><td align="left" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">241</td><td align="left" rowspan="1" colspan="1">476</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">243</td><td align="left" rowspan="1" colspan="1">499</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="nt105"><label>&#x0002a;</label><p>P, chi-square, or Fisher's exact test for cells less than 20.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0001395-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001395.t003</object-id><label>Table 3</label><caption><title>Pairwise linkage disequilibrium (D') and correlation coefficients (r<sup>2</sup>) between CRP polymorphisms and control women and men</title></caption><graphic id="pone-0001395-t003-3" xlink:href="pone.0001395.t003"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001395-t003-3"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Women</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td colspan="5" align="left" rowspan="1">Linkage Disequilibrium (D')</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Polymorphism</td><td align="left" rowspan="1" colspan="1">1919</td><td align="left" rowspan="1" colspan="1">2667</td><td align="left" rowspan="1" colspan="1">3014</td><td align="left" rowspan="1" colspan="1">3872</td><td align="left" rowspan="1" colspan="1">4741</td><td align="left" rowspan="1" colspan="1">5237</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Correlation Coefficient (r<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">1919</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">0.9838</td><td align="left" rowspan="1" colspan="1">0.9823</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2667</td><td align="left" rowspan="1" colspan="1">0.0235</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">0.9553</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">0.7563</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3014</td><td align="left" rowspan="1" colspan="1">0.9526</td><td align="left" rowspan="1" colspan="1">0.0237</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.9822</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">0.9611</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3872</td><td align="left" rowspan="1" colspan="1">0.2003</td><td align="left" rowspan="1" colspan="1">0.1034</td><td align="left" rowspan="1" colspan="1">0.2027</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4741</td><td align="left" rowspan="1" colspan="1">0.0278</td><td align="left" rowspan="1" colspan="1">0.0034</td><td align="left" rowspan="1" colspan="1">0.0260</td><td align="left" rowspan="1" colspan="1">0.0305</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5237</td><td align="left" rowspan="1" colspan="1">0.1945</td><td align="left" rowspan="1" colspan="1">0.0134</td><td align="left" rowspan="1" colspan="1">0.1729</td><td align="left" rowspan="1" colspan="1">0.2152</td><td align="left" rowspan="1" colspan="1">0.0269</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Men</td><td align="left" rowspan="1" colspan="1">Polymorphism</td><td align="left" rowspan="1" colspan="1">1919</td><td align="left" rowspan="1" colspan="1">2667</td><td align="left" rowspan="1" colspan="1">3014</td><td align="left" rowspan="1" colspan="1">3872</td><td align="left" rowspan="1" colspan="1">4741</td><td align="left" rowspan="1" colspan="1">5237</td></tr><tr><td align="left" rowspan="1" colspan="1">Correlation Coefficient (r<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">1919</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">0.9950</td><td align="left" rowspan="1" colspan="1">0.9835</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2667</td><td align="left" rowspan="1" colspan="1">0.0273</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">0.9680</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3014</td><td align="left" rowspan="1" colspan="1">0.9900</td><td align="left" rowspan="1" colspan="1">0.0270</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.9517</td><td align="left" rowspan="1" colspan="1">0.8431</td><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3872</td><td align="left" rowspan="1" colspan="1">0.1988</td><td align="left" rowspan="1" colspan="1">0.1260</td><td align="left" rowspan="1" colspan="1">0.1912</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.7588</td><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4741</td><td align="left" rowspan="1" colspan="1">0.0362</td><td align="left" rowspan="1" colspan="1">0.0050</td><td align="left" rowspan="1" colspan="1">0.1038</td><td align="left" rowspan="1" colspan="1">0.0209</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5237</td><td align="left" rowspan="1" colspan="1">0.1845</td><td align="left" rowspan="1" colspan="1">0.0242</td><td align="left" rowspan="1" colspan="1">0.1820</td><td align="left" rowspan="1" colspan="1">0.1822</td><td align="left" rowspan="1" colspan="1">0.0335</td><td align="left" rowspan="1" colspan="1">-</td></tr></tbody></table></table-wrap></sec><sec id="s3b"><title>CRP SNPs, plasma CRP levels, and risk of coronary heart disease</title><p>Under the additive model, 2667G&#x0003e;C was associated with an increased risk of CHD in both women (RR 1.57, 95&#x00025; confidence interval &#x0005b;CI&#x0005d; 1.01&#x02013;2.44) and men (RR 1.93, 95&#x00025; CI 1.30&#x02013;2.88); however, none of the other SNPs were associated with risk of CHD in both men and women (<xref ref-type="table" rid="pone-0001395-t004"><bold>Table 4</bold></xref>). Multivariable adjustment did not change these results. Furthermore, among the controls, individual SNPs were associated with plasma CRP levels, with similar associations and directions for both women and men (<xref ref-type="table" rid="pone-0001395-t004"><bold>Table 4</bold></xref>). Under the same model, SNPs 2667G&#x0003e;C and 3872C&#x0003e;T were associated with 22&#x02013;37&#x00025; lower CRP levels, whereas 4741G&#x0003e;C was associated with &#x0223c;40&#x00025; higher CRP levels. SNPs 1919A&#x0003e;T and 3014G&#x0003e;A were associated with approximately 20&#x00025; higher CRP levels, whereas 5237A&#x0003e;G was not associated with CRP levels in either men or women.</p><table-wrap id="pone-0001395-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001395.t004</object-id><label>Table 4</label><caption><title>Association of CRP SNPs with risk of coronary heart disease, and with plasma CRP levels among women and men</title></caption><graphic id="pone-0001395-t004-4" xlink:href="pone.0001395.t004"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001395-t004-4"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="5" align="left" rowspan="1">Women</td><td colspan="5" align="left" rowspan="1">Men</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cases/Controls</td><td align="left" rowspan="1" colspan="1">Odds ratio (95&#x00025; CI)<xref ref-type="table-fn" rid="nt106">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">p-value</td><td align="left" rowspan="1" colspan="1">Multiplicative change in CRP levels<xref ref-type="table-fn" rid="nt107">&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt108">&#x02021;</xref></td><td align="left" rowspan="1" colspan="1">Cases/Controls</td><td align="left" rowspan="1" colspan="1">Odds ratio (95&#x00025; CI)<xref ref-type="table-fn" rid="nt106">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1">p-value</td><td align="left" rowspan="1" colspan="1">Multiplicative change in CRP levels<xref ref-type="table-fn" rid="nt107">&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt108">&#x02021;</xref></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>1919A&#x0003e;T</bold></td><td align="left" rowspan="1" colspan="1">236/466</td><td align="left" rowspan="1" colspan="1">0.90 (0.70&#x02013;1.14)</td><td align="left" rowspan="1" colspan="1">0.37</td><td align="left" rowspan="1" colspan="1">1.22</td><td align="left" rowspan="1" colspan="1">0.009</td><td align="left" rowspan="1" colspan="1">244/487</td><td align="left" rowspan="1" colspan="1">0.93 (0.73&#x02013;1.18)</td><td align="left" rowspan="1" colspan="1">0.55</td><td align="left" rowspan="1" colspan="1">1.18</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>2667G&#x0003e;C</bold></td><td align="left" rowspan="1" colspan="1">241/482</td><td align="left" rowspan="1" colspan="1">1.57 (1.01&#x02013;2.44)</td><td align="left" rowspan="1" colspan="1">0.047</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">258/513</td><td align="left" rowspan="1" colspan="1">1.93 (1.30&#x02013;2.88)</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>3014G&#x0003e;A</bold></td><td align="left" rowspan="1" colspan="1">237/467</td><td align="left" rowspan="1" colspan="1">0.88 (0.69&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1">0.28</td><td align="left" rowspan="1" colspan="1">1.15</td><td align="left" rowspan="1" colspan="1">0.08</td><td align="left" rowspan="1" colspan="1">248/492</td><td align="left" rowspan="1" colspan="1">0.89 (0.70&#x02013;1.13)</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">1.22</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>3872C&#x0003e;T</bold></td><td align="left" rowspan="1" colspan="1">241/475</td><td align="left" rowspan="1" colspan="1">1.08 (0.85&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">254/508</td><td align="left" rowspan="1" colspan="1">1.17 (0.92&#x02013;1.48)</td><td align="left" rowspan="1" colspan="1">0.88</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>4741G&#x0003e;C</bold></td><td align="left" rowspan="1" colspan="1">238/470</td><td align="left" rowspan="1" colspan="1">1.22 (0.76&#x02013;1.94)</td><td align="left" rowspan="1" colspan="1">0.42</td><td align="left" rowspan="1" colspan="1">1.38</td><td align="left" rowspan="1" colspan="1">0.006</td><td align="left" rowspan="1" colspan="1">259/503</td><td align="left" rowspan="1" colspan="1">0.70 (0.44&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">0.12</td><td align="left" rowspan="1" colspan="1">1.41</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>5237A&#x0003e;G</bold></td><td align="left" rowspan="1" colspan="1">241/476</td><td align="left" rowspan="1" colspan="1">0.93 (0.72&#x02013;1.19)</td><td align="left" rowspan="1" colspan="1">0.56</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1">243/499</td><td align="left" rowspan="1" colspan="1">1.07 (0.84&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1">0.59</td><td align="left" rowspan="1" colspan="1">0.96</td><td align="left" rowspan="1" colspan="1">0.56</td></tr></tbody></table><table-wrap-foot><fn id="nt106"><label>&#x0002a;</label><p>Conditional logistic regression under the additive genetic model</p></fn><fn id="nt107"><label>&#x02020;</label><p>Matching factor-adjusted, log-transformed, multiplicative change per copy of the allele among controls</p></fn><fn id="nt108"><label>&#x02021;</label><p>P for change in CRP levels</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c"><title>CRP haplotypes, plasma CRP levels, and risk of coronary heart disease</title><p>Five common haplotypes (H1-H5) had an estimated frequency &#x02265;5&#x00025; (<xref ref-type="table" rid="pone-0001395-t005"><bold>Table 5</bold></xref>). H1 with minor alleles of 1919A&#x0003e;T and 3014G&#x0003e;A and major alleles of all others, was the most frequent haplotype and set as the reference haplotype in subsequent analyses. H2, with minor allele of 5237A&#x0003e;G, and H3, with minor allele of 3872C&#x0003e;T, had estimated frequencies ranging from 25&#x02013;30&#x00025;. Neither H2 nor H3 was associated with risk of CHD. However, H4, with an estimated frequency of 6&#x02013;7&#x00025;, was associated with an increased risk of CHD in both women (RR 1.66, 95&#x00025; CI 1.02&#x02013;2.71) and men (RR 1.90, 95&#x00025; CI 1.25&#x02013;2.88). The difference between H3 and H4 may be attributable to the minor allele of 2667G&#x0003e;C.</p><table-wrap id="pone-0001395-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001395.t005</object-id><label>Table 5</label><caption><title>Common CRP haplotypes, risk of CHD, and relative effects of haplotypes on plasma CRP levels</title></caption><graphic id="pone-0001395-t005-5" xlink:href="pone.0001395.t005"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001395-t005-5"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">CRP SNP</td><td align="left" rowspan="1" colspan="1">1919</td><td align="left" rowspan="1" colspan="1">2667</td><td align="left" rowspan="1" colspan="1">3014</td><td align="left" rowspan="1" colspan="1">3872</td><td align="left" rowspan="1" colspan="1">4741</td><td align="left" rowspan="1" colspan="1">5237</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Multiplicative change in CRP per copy relative to H1 among controls<xref ref-type="table-fn" rid="nt111">&#x02021;</xref></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Women</italic></td><td align="left" rowspan="1" colspan="1">A&#x0003e;T</td><td align="left" rowspan="1" colspan="1">G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Freq (&#x00025;)</td><td align="left" rowspan="1" colspan="1">OR (95&#x00025;CI)<xref ref-type="table-fn" rid="nt110">&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">p-value</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p-value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Haplotype #:</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">H1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">29.1</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">H2</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">30.7</td><td align="left" rowspan="1" colspan="1">1.01 (0.77&#x02013;1.34)</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">0.88</td><td align="left" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">H3</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">26.4</td><td align="left" rowspan="1" colspan="1">0.99 (0.74&#x02013;1.34)</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">H4</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">5.8</td><td align="left" rowspan="1" colspan="1">1.66 (1.02&#x02013;2.71)</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.56</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">H5</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">6.0</td><td align="left" rowspan="1" colspan="1">1.27 (0.79&#x02013;2.04)</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">1.19</td><td align="left" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">H6<xref ref-type="table-fn" rid="nt112">&#x000a7;</xref></td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">&#x0003c;5.0</td><td align="left" rowspan="1" colspan="1">0.93 (0.39&#x02013;2.24)</td><td align="left" rowspan="1" colspan="1">0.88</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt113">&#x000a5;</xref></td><td align="left" rowspan="1" colspan="1">0.37</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CRP SNP</td><td align="left" rowspan="1" colspan="1">1919</td><td align="left" rowspan="1" colspan="1">2667</td><td align="left" rowspan="1" colspan="1">3014</td><td align="left" rowspan="1" colspan="1">3872</td><td align="left" rowspan="1" colspan="1">4741</td><td align="left" rowspan="1" colspan="1">5237</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Multiplicative change in CRP per copy relative to H1 among controls<xref ref-type="table-fn" rid="nt111">&#x02021;</xref></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>Men</italic></td><td align="left" rowspan="1" colspan="1">A&#x0003e;T</td><td align="left" rowspan="1" colspan="1">G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">G&#x0003e;A</td><td align="left" rowspan="1" colspan="1">C&#x0003e;T</td><td align="left" rowspan="1" colspan="1">G&#x0003e;C</td><td align="left" rowspan="1" colspan="1">A&#x0003e;G</td><td align="left" rowspan="1" colspan="1">Freq (&#x00025;)</td><td align="left" rowspan="1" colspan="1">OR (95&#x00025;CI)<xref ref-type="table-fn" rid="nt110">&#x02020;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p-value</td></tr><tr><td align="left" rowspan="1" colspan="1">Haplotype #:</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">H1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">30.8</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Ref</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">H2</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">28.7</td><td align="left" rowspan="1" colspan="1">1.11 (0.84&#x02013;1.47)</td><td align="left" rowspan="1" colspan="1">0.45</td><td align="left" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">H3</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">24.8</td><td align="left" rowspan="1" colspan="1">1.03 (0.77&#x02013;1.37)</td><td align="left" rowspan="1" colspan="1">0.87</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">H4</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">7.1</td><td align="left" rowspan="1" colspan="1">1.90 (1.25&#x02013;2.88)</td><td align="left" rowspan="1" colspan="1">0.003</td><td align="left" rowspan="1" colspan="1">0.64</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">H5</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">6.7</td><td align="left" rowspan="1" colspan="1">0.82 (0.52&#x02013;1.30)</td><td align="left" rowspan="1" colspan="1">0.40</td><td align="left" rowspan="1" colspan="1">1.19</td><td align="left" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1">H6<xref ref-type="table-fn" rid="nt112">&#x000a7;</xref></td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">&#x0003c;5.0</td><td align="left" rowspan="1" colspan="1">1.04 (0.45&#x02013;2.39)</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.89</td></tr><tr><td align="left" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="nt113">&#x000a5;</xref></td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="nt109"><label>&#x0002a;</label><p>Cutoff set as &#x02265;5.0&#x00025;, based on 744 women and 781 men.</p></fn><fn id="nt110"><label>&#x02020;</label><p>Haplotype-specific ORs (multiplicative increase in odds per copy of haplotype) using unconditional logistic regression, adjusted for matching factors</p></fn><fn id="nt111"><label>&#x02021;</label><p>Log-transformed CRP adjusted for matching factors</p></fn><fn id="nt112"><label>&#x000a7;</label><p>All other haplotypes</p></fn><fn id="nt113"><label>&#x000a5;</label><p>Globally-adjusted likelihood ratio test</p></fn></table-wrap-foot></table-wrap><p>Where individual SNPs were associated with CRP levels, estimated haplotypes were associated with plasma CRP levels in a similar manner. The tagging SNPs for H1 were individually associated with higher CRP levels. Compared to H1, H3 and H4 were associated with 24&#x02013;44&#x00025; lower CRP levels among both men and women, and these findings were as expected from their individual variant alleles. For comparison, H1 and H5, which included the triallelic proxy, were both associated with higher CRP levels.</p><p>Overall, the global p-value comparing the model with haplotypes to the model without was not statistically significant among women (p&#x0200a;&#x0003d;&#x0200a;0.37) but significant among men (p&#x0200a;&#x0003d;&#x0200a;0.04).</p></sec></sec><sec id="s4"><title>Discussion</title><p>In two independent populations of predominantly Caucasian men and women, we related common variation in the CRP gene and estimated common haplotypes with plasma CRP levels and risk of incident CHD. CRP SNPs and associated haplotypes were strongly associated with plasma CRP levels. However, neither the individual SNPs nor common haplotypes were associated with risk of CHD in the direction that would be predicted by their association with CRP levels.</p><p>Inflammation is thought to contribute to increased cardiovascular risk, and C-reactive protein, an important component of the innate immune system, is the most extensively studied marker of inflammation.<xref ref-type="bibr" rid="pone.0001395-Ridker1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001395-Danesh1">&#x0005b;6&#x0005d;</xref> Many studies have reported individual single nucleotide polymorphisms (SNPs) to be significantly associated with baseline CRP levels (<xref ref-type="table" rid="pone-0001395-t006"><bold>Table 6</bold></xref>).<xref ref-type="bibr" rid="pone.0001395-Kathiresan1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Brull1">&#x0005b;13&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001395-Crawford1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Lange1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Obisesan1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Wang1">&#x0005b;37&#x0005d;</xref> Though some of the individual SNP results have been conflicting, our results are consistent with the majority of published findings.</p><table-wrap id="pone-0001395-t006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001395.t006</object-id><label>Table 6</label><caption><title>Brief summary of literature examining single CRP SNPs with CRP levels, and CHD where available</title></caption><graphic id="pone-0001395-t006-6" xlink:href="pone.0001395.t006"/><table frame="hsides" rules="groups" alternate-form-of="pone-0001395-t006-6"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Association with CRP levels</td><td colspan="3" align="left" rowspan="1">Association with CHD</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02191; levels</td><td align="left" rowspan="1" colspan="1">&#x02193; levels</td><td align="left" rowspan="1" colspan="1">no association</td><td align="left" rowspan="1" colspan="1">&#x02191; risk</td><td align="left" rowspan="1" colspan="1">&#x02193; risk</td><td align="left" rowspan="1" colspan="1">no association</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>1919A&#x0003e;T</bold></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Suk1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-SukDanik1">&#x0005b;20&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Obisesan1">&#x0005b;36&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>2667G&#x0003e;C</bold></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Crawford1">&#x0005b;21&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Suk1">&#x0005b;14&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001395-Russell1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-SukDanik1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Brull1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Kovacs1">&#x0005b;18&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Zee1">&#x0005b;15&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>3014G&#x0003e;A</bold></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Brull1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Russell1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Casas1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-SukDanik1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Kovacs1">&#x0005b;18&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Casas1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>3872C&#x0003e;T</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Russell1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-SukDanik1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>4741G&#x0003e;C</bold></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Wang1">&#x0005b;37&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>5237A&#x0003e;G</bold><xref ref-type="table-fn" rid="nt114">&#x0002a;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Kovacs1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-SukDanik1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Crawford1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref></td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="nt114"><label>&#x0002a;</label><p>SNP 5237 was in high LD with another commonly reported SNP -717A&#x0003e;G (rs2794521).</p></fn></table-wrap-foot></table-wrap><p>On the other hand, the studies that assessed common variation and haplotypes in the CRP gene with plasma CRP levels differed in SNP selection methodology and estimated haplotypes.<xref ref-type="bibr" rid="pone.0001395-Kathiresan1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Russell1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001395-Lange1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Carlson1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Wang1">&#x0005b;37&#x0005d;</xref> For example, Carlson et al.<xref ref-type="bibr" rid="pone.0001395-Carlson1">&#x0005b;32&#x0005d;</xref> resequenced 47 samples from panels with African American and European descent individuals to select seven tagging SNPs for eight haplotypes in the CARDIA study. On the other hand, Miller et al.<xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref> resequenced 192 individuals in the Women's Health Study with extreme discordant baseline CRP levels and selected seven tagging SNPs for six common haplotypes among Caucasians participants in three sub-cohorts. In the Rotterdam Study, Kardys et al. genotyped 3 tagging SNPs (3014, 3872, and 4741) selected from SeattleSNPs which were sufficient to infer four common haplotypes.<xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref> Though overall haplotypes were not exactly replicated, the more recent studies shared much overlap in selected SNPs. Based on LD patterns and similar reference groups, our results were similar to what has been previously reported. The haplotypes associated with lower CRP levels were similar, as were the haplotypes associated with higher CRP levels.</p><p>Several studies have shown H4 as associated with significantly lower CRP levels.<xref ref-type="bibr" rid="pone.0001395-Kathiresan1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Russell1">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Lange1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Carlson1">&#x0005b;32&#x0005d;</xref> However, specifically of importance, few studies have assessed haplotypes, and H4 in particular, with risk of incident CHD. Thus far, the results have been unclear and conflicting. Though the Rotterdam Study did not genotype 2667G&#x0003e;C, they reported four haplotypes significantly associated with CRP levels, and reported no associations with CHD.<xref ref-type="bibr" rid="pone.0001395-Kardys1">&#x0005b;22&#x0005d;</xref> A recent study in the Cardiovascular Health Study of older adults reported no association between five CRP haplotypes and risk of MI among white participants, and the relative risk of MI for our H4 equivalent was 0.93 (95&#x00025; CI 0.72&#x02013;1.21).<xref ref-type="bibr" rid="pone.0001395-Lange1">&#x0005b;24&#x0005d;</xref> On the other hand, though H4 was not associated with CRP levels in the Physicians' Health Study, 3872C&#x0003e;T individually was associated with lower CRP levels, and with an increased risk of MI (odds ratio: 1.29, 95&#x00025; CI 0.99&#x02013;1.67).<xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref> Furthermore, the odds ratio for 2667G&#x0003e;C was suggestive of a 50&#x00025; increase as well, but the confidence interval was much wider. Taken together, these results suggest that 2667G&#x0003e;C and 3872C&#x0003e;T, though associated with lower CRP levels, may be associated with an elevated risk of CHD.</p><p>A number of SNPs in the promoter region of the CRP gene have been shown to affect changes in transcription factor binding and gene promoter activity.<xref ref-type="bibr" rid="pone.0001395-Szalai2">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Carlson1">&#x0005b;32&#x0005d;</xref> The triallelic SNP has been associated with increased promoter activity and higher CRP levels,<xref ref-type="bibr" rid="pone.0001395-Carlson1">&#x0005b;32&#x0005d;</xref> and haplotypes of the promoter triallelic and rs3093032 SNPs affect transcription factor binding, transcriptional activity, and CRP levels.<xref ref-type="bibr" rid="pone.0001395-Szalai2">&#x0005b;17&#x0005d;</xref> The major alleles of 3872C&#x0003e;T and 5237A&#x0003e;G together serve as a proxy for the triallelic,<xref ref-type="bibr" rid="pone.0001395-Kathiresan1">&#x0005b;9&#x0005d;</xref> and the 2-SNP haplotype was associated with higher CRP levels in our studies as well as in others.<xref ref-type="bibr" rid="pone.0001395-Kathiresan1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Carlson1">&#x0005b;32&#x0005d;</xref> Otherwise, more functionality data are needed for CRP SNPs.</p><p>There is emerging consistency in the literature that polymorphisms in the CRP gene are associated with plasma CRP levels, but whether there is also an association between polymorphisms and risk of coronary events remains unclear. While CRP polymorphisms are strongly associated with plasma levels, these polymorphisms contribute only 1.4&#x02013;5.0&#x00025; of the phenotypic variation, a level comparable to (or less than) that from environmental and lifestyle factors.<xref ref-type="bibr" rid="pone.0001395-Kathiresan1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001395-Miller1">&#x0005b;23&#x0005d;</xref> In addition to environmental stimuli, CRP is induced by other inflammatory cytokines, and additional genes in the inflammatory pathway may regulate CRP levels as well. Thus, our results are consistent with CRP as a good indicator of the inflammatory state and as a risk marker. However, the apparent influence in baseline CRP levels due to CRP polymorphisms may not be large enough to alter CHD risk, which may explain the lack of association between the majority of common haplotypes in the CRP gene and risk of CHD in either the NHS or the HPFS. The remaining exception would be haplotype 4, and it is possible that CRP is an epiphenomenon of vascular inflammation and not directly involved in vascular pathobiology, or possibly protective. Alternatively, the CRP polymorphisms and haplotypes may be in LD with pro-atherogenic variants in nearby gene regions which would not be captured in this study.</p><p>Several potential limitations should be discussed regarding the current two studies. In genetic association studies, population stratification is often a concern. However, population stratification should be minimized in the NHS and HPFS because both cohorts are predominantly Caucasian, and similar results were observed when restricted to Caucasians only. Additionally, we recognize that the relative socioeconomic homogeneity of the cohorts does not represent random samples of U.S. men and women and may not be generalizeable to other populations. Though the homogeneity is unlikely to influence genetic predisposition, it may be a strength in reducing residual confounding from unmeasured factors related to socioeconomic status. Also, the distribution of cardiovascular risk factors such as smoking status and history of diabetes were different between the men and women, and may have mediated influences through CRP. Finally, chance may be an explanation for the statistically significant findings. Nevertheless, we included a replication study by examining both the NHS and HPFS, and the overall results were identical between the two independent populations.</p><p>Our study provides a comprehensive assessment of the common genetic variation in the CRP gene with plasma CRP levels and risk of incident CHD among two independent populations. Among predominantly Caucasian men and women, CRP genotypes and haplotypes were consistently and significantly associated with plasma CRP levels. However, the relationship between genotype and CRP levels did not translate largely to an associated change in CHD risk, and Haplotype 4 in particular may be important in predicting other clinical events. These data suggest that the underlying inflammatory processes which predict coronary events cannot be captured solely by variation in the CRP gene, and other regulatory genes should be examined.</p></sec></body><back><ack><p>The authors acknowledge Dr. David Hunter for his guidance in SNP selection and genotyping expertise, and Dr. JoAnn Manson for her valued support through the cardiovascular research program.</p></ack><ref-list><title>References</title><ref id="pone.0001395-Libby1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname><given-names>P</given-names></name></person-group><year>2002</year><article-title>Inflammation in atherosclerosis.</article-title><source>Nature</source><volume>420</volume><fpage>868</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">12490960</pub-id></citation></ref><ref id="pone.0001395-Szalai1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szalai</surname><given-names>AJ</given-names></name></person-group><year>2002</year><article-title>The biological functions of C-reactive protein.</article-title><source>Vascul Pharmacol</source><volume>39</volume><fpage>105</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">12616974</pub-id></citation></ref><ref id="pone.0001395-Ridker1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name></person-group><year>1997</year><article-title>Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.</article-title><source>N Engl J Med</source><volume>336</volume><fpage>973</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">9077376</pub-id></citation></ref><ref id="pone.0001395-Ridker2"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name></person-group><year>2000</year><article-title>C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.</article-title><source>N Engl J Med</source><volume>342</volume><fpage>836</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">10733371</pub-id></citation></ref><ref id="pone.0001395-Pai1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname><given-names>JK</given-names></name><name><surname>Pischon</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Hankinson</surname><given-names>SE</given-names></name><etal/></person-group><year>2004</year><article-title>Inflammatory markers and the risk of coronary heart disease in men and women.</article-title><source>N Engl J Med</source><volume>351</volume><fpage>2599</fpage><lpage>2610</lpage><pub-id pub-id-type="pmid">15602020</pub-id></citation></ref><ref id="pone.0001395-Danesh1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Wheeler</surname><given-names>JG</given-names></name><name><surname>Hirschfield</surname><given-names>GM</given-names></name><name><surname>Eda</surname><given-names>S</given-names></name><name><surname>Eiriksdottir</surname><given-names>G</given-names></name><etal/></person-group><year>2004</year><article-title>C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.</article-title><source>N Engl J Med</source><volume>350</volume><fpage>1387</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">15070788</pub-id></citation></ref><ref id="pone.0001395-Ledue1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ledue</surname><given-names>TB</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name></person-group><year>2003</year><article-title>Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment.</article-title><source>Clin Chem</source><volume>49</volume><fpage>1258</fpage><lpage>1271</lpage><pub-id pub-id-type="pmid">12881440</pub-id></citation></ref><ref id="pone.0001395-Ford1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>ES</given-names></name><name><surname>Giles</surname><given-names>WH</given-names></name><name><surname>Mokdad</surname><given-names>AH</given-names></name><name><surname>Myers</surname><given-names>GL</given-names></name></person-group><year>2004</year><article-title>Distribution and correlates of C-reactive protein concentrations among adult US women.</article-title><source>Clin Chem</source><volume>50</volume><fpage>574</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">14709450</pub-id></citation></ref><ref id="pone.0001395-Kathiresan1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Guo</surname><given-names>CY</given-names></name><name><surname>Gona</surname><given-names>P</given-names></name><etal/></person-group><year>2006</year><article-title>Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.</article-title><source>Circulation</source><volume>113</volume><fpage>1415</fpage><lpage>1423</lpage><pub-id pub-id-type="pmid">16534007</pub-id></citation></ref><ref id="pone.0001395-deMaat1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Maat</surname><given-names>MP</given-names></name><name><surname>Trion</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>C-reactive protein as a risk factor versus risk marker.</article-title><source>Curr Opin Lipidol</source><volume>15</volume><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">15529024</pub-id></citation></ref><ref id="pone.0001395-Pankow1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pankow</surname><given-names>JS</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><name><surname>Borecki</surname><given-names>IB</given-names></name><name><surname>Hopkins</surname><given-names>PN</given-names></name><etal/></person-group><year>2001</year><article-title>Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study.</article-title><source>Atherosclerosis</source><volume>154</volume><fpage>681</fpage><lpage>689</lpage><pub-id pub-id-type="pmid">11257270</pub-id></citation></ref><ref id="pone.0001395-Dupuis1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dupuis</surname><given-names>J</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Massaro</surname><given-names>JM</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><etal/></person-group><year>2005</year><article-title>Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q.</article-title><source>Atherosclerosis</source><volume>182</volume><fpage>307</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">16159603</pub-id></citation></ref><ref id="pone.0001395-Brull1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brull</surname><given-names>DJ</given-names></name><name><surname>Serrano</surname><given-names>N</given-names></name><name><surname>Zito</surname><given-names>F</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Montgomery</surname><given-names>HE</given-names></name><etal/></person-group><year>2003</year><article-title>Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>23</volume><fpage>2063</fpage><lpage>2069</lpage><pub-id pub-id-type="pmid">12842840</pub-id></citation></ref><ref id="pone.0001395-Suk1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suk</surname><given-names>HJ</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Zee</surname><given-names>RY</given-names></name></person-group><year>2005</year><article-title>Relation of polymorphism within the C-reactive protein gene and plasma CRP levels.</article-title><source>Atherosclerosis</source><volume>178</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">15585211</pub-id></citation></ref><ref id="pone.0001395-Zee1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zee</surname><given-names>RY</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group><year>2002</year><article-title>Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis.</article-title><source>Atherosclerosis</source><volume>162</volume><fpage>217</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">11947917</pub-id></citation></ref><ref id="pone.0001395-Russell1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>AI</given-names></name><name><surname>Cunninghame Graham</surname><given-names>DS</given-names></name><name><surname>Shepherd</surname><given-names>C</given-names></name><name><surname>Roberton</surname><given-names>CA</given-names></name><name><surname>Whittaker</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus.</article-title><source>Hum Mol Genet</source><volume>13</volume><fpage>137</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">14645206</pub-id></citation></ref><ref id="pone.0001395-Szalai2"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szalai</surname><given-names>AJ</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Lange</surname><given-names>EM</given-names></name><name><surname>McCrory</surname><given-names>MA</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><etal/></person-group><year>2005</year><article-title>Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level.</article-title><source>J Mol Med</source><volume>83</volume><fpage>440</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">15778807</pub-id></citation></ref><ref id="pone.0001395-Kovacs1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kovacs</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>F</given-names></name><name><surname>Hansson</surname><given-names>LO</given-names></name><name><surname>Lundman</surname><given-names>P</given-names></name><name><surname>Samnegard</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein.</article-title><source>Atherosclerosis</source><volume>178</volume><fpage>193</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">15585218</pub-id></citation></ref><ref id="pone.0001395-Casas1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname><given-names>JP</given-names></name><name><surname>Shah</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>J</given-names></name><name><surname>Hawe</surname><given-names>E</given-names></name><name><surname>McMahon</surname><given-names>AD</given-names></name><etal/></person-group><year>2006</year><article-title>Insight into the nature of the CRP-coronary event association using Mendelian randomization.</article-title><source>Int J Epidemiol</source><volume>35</volume><fpage>922</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">16565153</pub-id></citation></ref><ref id="pone.0001395-SukDanik1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suk Danik</surname><given-names>J</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Cannon</surname><given-names>CP</given-names></name><name><surname>Miller</surname><given-names>DT</given-names></name><name><surname>Zee</surname><given-names>RY</given-names></name><etal/></person-group><year>2006</year><article-title>Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia.</article-title><source>Ann Hum Genet</source><volume>70</volume><fpage>705</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">17044845</pub-id></citation></ref><ref id="pone.0001395-Crawford1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname><given-names>DC</given-names></name><name><surname>Sanders</surname><given-names>CL</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Shephard</surname><given-names>C</given-names></name><etal/></person-group><year>2006</year><article-title>Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey.</article-title><source>Circulation</source><volume>114</volume><fpage>2458</fpage><lpage>2465</lpage><pub-id pub-id-type="pmid">17101857</pub-id></citation></ref><ref id="pone.0001395-Kardys1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kardys</surname><given-names>I</given-names></name><name><surname>de Maat</surname><given-names>MP</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>JC</given-names></name></person-group><year>2006</year><article-title>C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study.</article-title><source>Eur Heart J</source><volume>27</volume><fpage>1331</fpage><lpage>1337</lpage><pub-id pub-id-type="pmid">16682383</pub-id></citation></ref><ref id="pone.0001395-Miller1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>DT</given-names></name><name><surname>Zee</surname><given-names>RY</given-names></name><name><surname>Suk Danik</surname><given-names>J</given-names></name><name><surname>Kozlowski</surname><given-names>P</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><etal/></person-group><year>2005</year><article-title>Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events.</article-title><source>Ann Hum Genet</source><volume>69</volume><fpage>623</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">16266402</pub-id></citation></ref><ref id="pone.0001395-Lange1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Carlson</surname><given-names>CS</given-names></name><name><surname>Hindorff</surname><given-names>LA</given-names></name><name><surname>Lange</surname><given-names>EM</given-names></name><name><surname>Walston</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.</article-title><source>Jama</source><volume>296</volume><fpage>2703</fpage><lpage>2711</lpage><pub-id pub-id-type="pmid">17164456</pub-id></citation></ref><ref id="pone.0001395-Colditz1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colditz</surname><given-names>GA</given-names></name></person-group><year>1995</year><article-title>The nurses' health study: a cohort of US women followed since 1976.</article-title><source>J Am Med Womens Assoc</source><volume>50</volume><fpage>40</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">7722205</pub-id></citation></ref><ref id="pone.0001395-Rimm1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rimm</surname><given-names>EB</given-names></name><name><surname>Giovannucci</surname><given-names>EL</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Litin</surname><given-names>LB</given-names></name><etal/></person-group><year>1992</year><article-title>Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals.</article-title><source>Am J Epidemiol</source><volume>135</volume><fpage>1114</fpage><lpage>1136</lpage><pub-id pub-id-type="pmid">1632423</pub-id></citation></ref><ref id="pone.0001395-Prentice1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prentice</surname><given-names>RL</given-names></name><name><surname>Breslow</surname><given-names>NE</given-names></name></person-group><year>1978</year><article-title>Retrospective studies and failure time models.</article-title><source>Biometrika</source><volume>65</volume><fpage>153</fpage><lpage>158</lpage></citation></ref><ref id="pone.0001395-Rose1"><label>28</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>GA</given-names></name><name><surname>Blackburn</surname><given-names>H</given-names></name></person-group><year>1982</year><article-title>Cardiovascular survey methods. WHO Monograph Series No 58.</article-title><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></citation></ref><ref id="pone.0001395-Luepker1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luepker</surname><given-names>RV</given-names></name><name><surname>Apple</surname><given-names>FS</given-names></name><name><surname>Christenson</surname><given-names>RH</given-names></name><name><surname>Crow</surname><given-names>RS</given-names></name><name><surname>Fortmann</surname><given-names>SP</given-names></name><etal/></person-group><year>2003</year><article-title>Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.</article-title><source>Circulation</source><volume>108</volume><fpage>2543</fpage><lpage>2549</lpage><pub-id pub-id-type="pmid">14610011</pub-id></citation></ref><ref id="pone.0001395-Pai2"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname><given-names>JK</given-names></name><name><surname>Curhan</surname><given-names>GC</given-names></name><name><surname>Cannuscio</surname><given-names>CC</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><etal/></person-group><year>2002</year><article-title>Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection.</article-title><source>Clin Chem</source><volume>48</volume><fpage>1781</fpage><lpage>1784</lpage><pub-id pub-id-type="pmid">12324497</pub-id></citation></ref><ref id="pone.0001395-Pischon1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pischon</surname><given-names>T</given-names></name><name><surname>Hankinson</surname><given-names>SE</given-names></name><name><surname>Hotamisligil</surname><given-names>GS</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name></person-group><year>2003</year><article-title>Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers.</article-title><source>Obes Res</source><volume>11</volume><fpage>1055</fpage><lpage>1064</lpage><pub-id pub-id-type="pmid">12972675</pub-id></citation></ref><ref id="pone.0001395-Carlson1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>CS</given-names></name><name><surname>Aldred</surname><given-names>SF</given-names></name><name><surname>Lee</surname><given-names>PK</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Schwartz</surname><given-names>SM</given-names></name><etal/></person-group><year>2005</year><article-title>Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.</article-title><source>Am J Hum Genet</source><volume>77</volume><fpage>64</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">15897982</pub-id></citation></ref><ref id="pone.0001395-The1"><label>33</label><citation citation-type="journal"><collab>The International HapMap Consortium</collab><year>2005</year><article-title>A haplotype map of the human genome.</article-title><source>Nature</source><volume>437</volume><fpage>1299</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">16255080</pub-id></citation></ref><ref id="pone.0001395-Zaykin1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zaykin</surname><given-names>DV</given-names></name><name><surname>Westfall</surname><given-names>PH</given-names></name><name><surname>Young</surname><given-names>SS</given-names></name><name><surname>Karnoub</surname><given-names>MA</given-names></name><name><surname>Wagner</surname><given-names>MJ</given-names></name><etal/></person-group><year>2002</year><article-title>Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals.</article-title><source>Hum Hered</source><volume>53</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">12037407</pub-id></citation></ref><ref id="pone.0001395-Kraft1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Cox</surname><given-names>DG</given-names></name><name><surname>Paynter</surname><given-names>RA</given-names></name><name><surname>Hunter</surname><given-names>D</given-names></name><name><surname>De Vivo</surname><given-names>I</given-names></name></person-group><year>2005</year><article-title>Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques.</article-title><source>Genet Epidemiol</source><volume>28</volume><fpage>261</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">15637718</pub-id></citation></ref><ref id="pone.0001395-Obisesan1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Obisesan</surname><given-names>TO</given-names></name><name><surname>Leeuwenburgh</surname><given-names>C</given-names></name><name><surname>Phillips</surname><given-names>T</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Phares</surname><given-names>DA</given-names></name><etal/></person-group><year>2004</year><article-title>C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>24</volume><fpage>1874</fpage><lpage>1879</lpage><pub-id pub-id-type="pmid">15271790</pub-id></citation></ref><ref id="pone.0001395-Wang1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Hunt</surname><given-names>SC</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>YE</given-names></name><name><surname>Province</surname><given-names>MA</given-names></name><etal/></person-group><year>2006</year><article-title>Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study.</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>291</volume><fpage>H2752</fpage><lpage>2757</lpage><pub-id pub-id-type="pmid">16731635</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This study was supported by grants (HL35464, CA55075, and HL34594) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 